Invasive Aspergillus infections in allo-SCT recipients: Environmental sampling, nasal and oral colonization and galactomannan testing

Bone Marrow Transplantation

Volumn 45, Issue 2, 2010, Pages 333-338

  Nihtinen, A ^a   Anttila, V J ^a   Richardson, M ^b   Ruutu, T ^a   Juvonen, E ^a   Meri, T ^b   Volin, L ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Aspergillus; Colonization; Galactomannan; SCT

Indexed keywords

ACICLOVIR; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B DEOXYCHOLATE; BETA LACTAM; BUSULFAN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; GALACTOMANNAN; METHOTREXATE; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM; THYMOCYTE ANTIBODY; TOBRAMYCIN; TREOSULFAN;

ADULT; AIR QUALITY; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; APLASTIC ANEMIA; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BACTERIAL COLONIZATION; CONTROLLED STUDY; DRUG MEGADOSE; ENVIRONMENTAL ASPECTS AND RELATED PHENOMENA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEBRILE NEUTROPENIA; FEMALE; GRAFT VERSUS HOST REACTION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG INFECTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; MULTIPLE CYCLE TREATMENT; NOSE SMEAR; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; SPECIES INVASION; TREATMENT DURATION; WHOLE BODY RADIATION;

AIR MICROBIOLOGY; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MANNANS; MOUTH; NOSE; PATIENT ISOLATION;

EID: 76749171600     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.169     Document Type: Article

References (33)

1. Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H et al. False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. J Antimicrob Chemother 2008; 61: 411-416.
2. GrowWB, Moreb JS, Roque D, Manion K, Leather H, Reddy V et al. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant 2002; 29: 15-19.
3. Jantunen E, Ruutu P, Piilonen A, Volin L, Parkkali T, Ruutu T. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000; 26: 759-762. (Pubitemid 30806748)
4. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358-4366.
5. Morgan J, Wannemuehler KA, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005; 43: S49-S58.
6. Rovira M, Jiménez M, De La Bellacasa JP, Mensa J, Rafel M, Ortega M et al. Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective study. Transplantation 2004; 77: 1260-1264.
7. Aisner J, Murillo J, Schimpff SC, Steere AC. Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann Intern Med 1979; 90: 4-9.
8. Newman KA, Schimpff SC, Young VM, Wiernik PH. Lessons learned from surveillance cultures in patients with acute nonlymphocytic leukemia. Usefulness for epidemiologic, preventive and therapeutic research. Am J Med 1981; 70: 423-431.
9. Richardson MD, Rennie S, Marshall I, Morgan MG, Murphy JA, Shankland GS et al. Fungal surveillance of an open haematology ward. J Hosp Infect 2000; 45: 288-292.
10. Bénet T, Nicolle MC, Thiebaut A, Piens MA, Nicolini FE, Thomas X et al. Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure. Clin Infect Dis 2007; 45: 682-686.
11. Falvey DG, Streifel AJ. Ten-year air sample analysis of Aspergillus prevalence in a university hospital. J Hosp Infect 2007; 67: 35-41.
12. Leenders ACAP, van Belkum A, Behrendt M, Luijendijk AD, Verbrugh HA. Density and molecular epidemiology of Aspegillus in air and relationship to outbreaks of Aspergillus infection. J Clin Microbiol 1999; 37: 1752-1757.
13. Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, Chiba S et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-3)-beta-Dglucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42: 2733-2741.
14. Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol 1999; 37: 3223-3228.
15. Stynen D, Goris A, Sarfati J, Latge JP. A new sensitive sandwhich enzyme-linked immonusorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995; 33: 497-500.
16. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
17. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898-1906.
18. Maertens J, Theunissen K, Verbeken E, Lagrou K, Verhaegen J, Boogaerts M et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004; 126: 852-860.
19. Bart-Delabesse E, Basile M, Al Jijakli A, Souville D, Gay F, Philippe B et al. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J Clin Microbiol 2005; 43: 5214-5220.
20. Hamaki T, Kami M, Kanda Y, Miyakoshi S, Ueyama J, Morinaga S et al. False-positive results of Aspergillus enzymelinked immunosorbent assay in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation [letter]. Bone Marrow Transplant 2001; 28: 633-634.
21. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40: 1762-1769.
22. Racil Z, Kocmanova I, Lengerova M, Winterova J, Mayer J. Intravenous PLASMA-LYTE as a major cause of falsepositive results of platelia Aspergillus test for galactomannan detection in serum. J Clin Microbiol 2007; 45: 3141-3142.
23. Sulahian A, Touratier S, Ribaud P. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003; 349: 2366-2367.
24. Surmont I, Stockman W. Gluconate-containing intravenous solutions: another cause of false-positive galactomannan assay reactivity [letter]. J Clin Microbiol 2007; 45: 1373.
25. Casper J, Knauf W, Kiefer T, Wolff D, Steiner B, Hammer U et al. Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood 2004; 103: 725-731.
26. Ruutu T, Volin L, Parkkali T, Juvonen E, Elonen E. Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study. Blood 2000; 96: 2391-2398.
27. Evans EGV, Richrdson MD (eds) Medical Mycology: A Practical Approach. IRL Press at Oxford University Press: Oxford, 1989.
28. Sherertz RJ, Belani A, Kramer BS, Elfenbein GJ, Weiner RS, Sullivan ML et al. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med 1987; 83: 709-717.
29. Nihtinen A, Anttila VJ, Richardson M, Meri T, Volin L, Ruutu T. The utility of intensified environmental surveillance for pathogenic moulds in a stem cell transplantation ward during construction work to monitor the efficacy of HEPA filtration. Bone Marrow Transplant 2007; 40: 457-460.
30. Martino P, Raccah R, Gentile G, Venditti M, Girmenia C, Mandelli F. Aspergillus colonization of the nose and pulmonary aspergillosis in neutropneia patients: a retrospective study. Haematologica 1989; 74: 263-265.
31. Foy PC, van Burik JAH, Weisdorf DJ. Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 440-443.
32. Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive Aspergillosis in allogeneic stem cell recipients. J Infect Dis 2002; 186: 1297-1306.
33. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190: 641-649.